The prevention and treatment of cytomegalovirus infection in haematopoietic stem cell transplantation

被引：0
|
作者：
Mark Tuthill
Frederick Chen
Samantha Paston
Hugo De La Peña
Sylvie Rusakiewicz
Alejandro Madrigal
机构：
[1] The Anthony Nolan Research Institute,
[2] Royal Free Hospital,undefined
来源：
Cancer Immunology, Immunotherapy | 2009年 / 58卷
关键词：
CMV; Vaccine; Adoptive cellular therapy; Artificial antigen presenting cells;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Allogeneic haematopoietic stem cell transplantation (HSCT) is an intensive medical treatment involving myeloablative chemo-radiotherapy followed by stem cell rescue using allogeneic haematopoietic stem cells harvested from HLA-matched donors, which is primarily used for the treatment of haematological malignancies. Cytomegalovirus (CMV) infection is one of the major causes of morbidity and death after HSCT. This focused research review highlights the advances made with research into CMV in the HSCT setting. It provides the reader with an overview of current CMV research into the prevention and management of CMV infection.
引用
收藏
页码：1481 / 1488
页数：7
相关论文
共 50 条
  • [1] The prevention and treatment of cytomegalovirus infection in haematopoietic stem cell transplantation
    Tuthill, Mark
    Chen, Frederick
    Paston, Samantha
    De La Pena, Hugo
    Rusakiewicz, Sylvie
    Madrigal, Alejandro
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 2009, 58 (09) : 1481 - 1488
  • [2] Role of letermovir for prevention of cytomegalovirus infection after allogeneic haematopoietic stem cell transplantation
    Razonable, Raymund R.
    CURRENT OPINION IN INFECTIOUS DISEASES, 2018, 31 (04) : 286 - 291
  • [3] Treatment of cytomegalovirus infection with oral valganciclovir in allogeneic haematopoietic stem cell transplantation
    Uresandi, A
    Bermudez, A
    Yañez, L
    Gonzalez-Mesones, B
    Puente, M
    Baro, J
    Conde, E
    Iriondo, A
    BONE MARROW TRANSPLANTATION, 2006, 37 : S187 - S187
  • [4] Surveillance of cytomegalovirus infection in haematopoietic stem cell transplantation patients
    Bonon, SHA
    Menoni, SMF
    Rossi, CL
    De Souza, CA
    Vigorito, AC
    Costa, DB
    Costa, SCB
    JOURNAL OF INFECTION, 2005, 50 (02) : 130 - 137
  • [5] Cytomegalovirus infection in children after allogeneic haematopoietic stem cell transplantation in a developing country
    Hazar, V.
    Uygun, V.
    Karasu, G.
    Eker, N.
    Tayfun, F.
    Kupesiz, A.
    Yesilipek, A.
    BONE MARROW TRANSPLANTATION, 2013, 48 : S332 - S332
  • [6] Risk assessment in haematopoietic stem cell transplantation: GvHD prevention and treatment
    Holler, Ernst
    BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY, 2007, 20 (02) : 281 - 294
  • [7] Impact of cytomegalovirus infection on T-cell function after allogeneic haematopoietic stem cell transplantation
    Giebel, S
    Maccario, R
    Avanzini, MA
    Marconi, M
    Rossi, G
    Gentile, R
    Locatelli, F
    BONE MARROW TRANSPLANTATION, 2004, 33 : S191 - S192
  • [8] Risk Factors for Cytomegalovirus Infection after Haematopoietic Stem Cell Transplantation: A Meta-Analysis
    Wu, Si-Ting
    Wang, Chun-Li
    Wang, Li
    Zhang, Cai-Yun
    JCPSP-JOURNAL OF THE COLLEGE OF PHYSICIANS AND SURGEONS PAKISTAN, 2024, 34 (11): : 1347 - 1354
  • [9] FREQUENCY AND OUTCOME OF CYTOMEGALOVIRUS INFECTION IN RECIPIENTS OF HAEMATOPOIETIC STEM CELL TRANSPLANTATION - AN EXPERIENCE FROM PAKISTAN
    Ali, Natasha
    Khan, Zurrya
    Shaikh, Mohammad Usman
    Fadoo, Zehra
    Adil, Salman
    BONE MARROW TRANSPLANTATION, 2024, 59 : 476 - 477
  • [10] Foscarnet for cytomegalovirus infection after allogeneic haematopoietic stem cell transplantation from related donor
    Suzuki, R.
    Asakura, M.
    Ikegame, K.
    Yoshihara, S.
    Taniguchi, S.
    Mori, T.
    Etoh, T.
    Takami, A.
    Yoshida, T.
    Fukuda, T.
    Hatanaka, K.
    Kanamori, H.
    Yujiri, T.
    Atsuta, Y.
    Sakamaki, H.
    Ogawa, H.
    BONE MARROW TRANSPLANTATION, 2010, 45 : S220 - S220
12345